Related Experiment Video
Updated: Nov 22, 2025
08:42
A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit
Published on: November 21, 2023
1.5K
Degenerative osteoarthritis a reversible chronic disease
V Di Nicola1,2
1West Sussex Hospitals NHS Foundation Trust, Worthing Hospital, BN112DH, UK.
Regenerative Therapy
|January 11, 2021
Summary
Osteoarthritis (OA) is a common disabling joint disorder. This review explores how mesenchymal stem cells (MSCs) and regenerative therapies like PRP and exosomes may reverse early OA progression.
Area of Science:
- Orthopedics and Regenerative Medicine
- Musculoskeletal Disorders
- Immunology
Background:
- Osteoarthritis (OA) is the most prevalent chronic musculoskeletal condition, a leading cause of disability in older adults.
- OA involves a progressive degenerative cycle affecting the entire joint, including inflammation, cartilage breakdown, and bone erosion.
- Early OA is characterized by inflammatory-immunologic processes and the involvement of specific cells like synoviocytes and chondrocytes.
Purpose of the Study:
- To investigate the role of joint-resident mesenchymal stem cells (MSCs) in maintaining joint homeostasis and tissue repair.
- To explore the potential of minimally invasive interventions for halting and reversing early-stage OA.
- To review regenerative therapies including platelet-rich plasma (PRP), MSCs, and exosomes for OA treatment.
Main Methods:
- Literature review focusing on the pathophysiology of osteoarthritis.
- Analysis of the role of resident mesenchymal stem cells (MSCs) in joint regeneration.
- Examination of current and emerging regenerative interventions for early OA.
Main Results:
- Mesenchymal stem cells (MSCs) play a crucial homeostatic role, regulating cell turnover and tissue repair within the joint.
- MSCs establish and maintain a local regenerative microenvironment essential for joint health.
- Understanding OA pathogenesis highlights mechanisms for regenerative interventions.
Conclusions:
- Minimally invasive interventions targeting the regenerative microenvironment hold promise for early OA.
- Platelet-rich plasma (PRP), MSCs, and exosomes are key regenerative therapies to consider for OA.
- Further research into MSC-based therapies could offer new avenues for OA treatment and reversal.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.2K
01:29Bone Disorders
4.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.9K
01:22Chronic Obstructive Pulmonary Disease
1.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.9K
01:26Atherosclerosis III: Management
131
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
131